An early analysis in Britain found that the vaccine had an efficacy rate of nearly 90 percent. But in a small South Africa trial, the efficacy rate dropped to just under 50 percent.
Published: January 28, 2021 at 10:05PM
from NYT Health https://ift.tt/3t04Lwl